Large-scale, coordinated insider selling by all top executives raises concerns about confidence in near-term prospects. Traders should watch for downward price pressure and monitor upcoming earnings or clinical trial updates for potential catalysts.
Price Chart
Executive Summary
Seven corporate insiders at Vera Therapeutics, including the CEO, CFO, and other C-suite executives, collectively sold over $1.4 million in shares on February 23, 2026, all at the same price of $41.9839 per share. This represents a coordinated, open-market divestment by top leadership, with the CEO alone selling nearly $711,000 worth of stock.
Key Financial Metrics
Key Facts
- All seven transactions were open-market sales (Form 4 code 'S') on the same day at the same price.
- Total value of sales: $1,406,040.71.
- CEO Marshall Fordyce sold 16,925 shares ($710,577.51), the largest individual transaction.
- All insiders are current C-suite executives, indicating broad-based selling at the highest level of management.
- No purchases or non-cash transactions (e.g., A, F, M) were included in this cluster.
Financial Impact
$1.4 million in insider selling over a single day
Risk Factors
- Loss of insider confidence may signal upcoming negative developments.
- Increased selling pressure from further insider divestments.
- Potential misalignment between management and shareholders if no clear rationale is provided.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (7 trades, 7d window) | cluster-VERA-1772109079428 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 8-K | $33.67 $34.00 | ▲ +0.98% | ▲ +0.16% | $30.13 (−10.53%) |
Aug 10, 2026 7w ago | 8-K | $30.29 $32.28 | ▲ +6.57% | ▲ +6.97% | $30.13 (−0.54%) |
Aug 10, 2026 7w ago | Press Release | $30.29 $32.28 | ▲ +6.57% | ▲ +6.97% | $30.13 (−0.54%) |
Jul 9, 2026 12w ago | 8-K | $42.45 $39.12 | ▼ −7.84% | ▼ −7.71% | $30.13 (−29.03%) |
Jul 7, 2026 12w ago | 8-K | $42.96 $43.13 | ▲ +0.40% | ▼ −0.16% | $30.13 (−29.88%) |
Jun 11, 2026 16w ago | Institutional Cluster | $33.65 $35.01 | ▲ +4.04% | ▲ +3.61% | $30.13 (−10.48%) |
Jun 2, 2026 17w ago | 8-K | $31.26 $31.81 | ▲ +1.76% | ▲ +4.72% | $30.13 (−3.63%) |
Jun 2, 2026 17w ago | Press Release | $31.26 $31.81 | ▲ +1.76% | ▲ +4.72% | $30.13 (−3.63%) |
May 7, 2026 21w ago | 8-K | $35.88 $39.15 | ▲ +9.11% | ▲ +7.61% | $30.13 (−16.04%) |
Feb 26, 2026 31w ago | 8-K | $42.35 $38.85 | ▼ −8.26% | ▼ −7.14% | $30.13 (−28.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access